Treatment of Osteoid Osteoma When Percutaneous Ablation Has Not Achieved the Expected Outcomes

Percutaneous thermal ablation is widely used as first-line minimally invasive treatment for osteoid osteoma. When the defined clinical endpoints are not met following ablation, a structured escalation protocol applies.

Previous Treatment & Failure Condition

This protocol is indicated when percutaneous thermal ablation — radiofrequency ablation, interstitial laser ablation, or cryoablation — has failed to reach the following goals:

Pain resolution following the procedure
Healing of the osteoid osteoma and resolution of bone marrow oedema at 12 months

Non-achievement of these endpoints defines the failure condition that escalates management to the next treatment line.

Next-Line Approach (Partial Overview)

The escalation protocol involves a direct surgical approach to the osteoma — a well-established operative strategy with consistently high success rates in the literature. The specific technique, patient selection criteria, and procedural detail are contained in the full protocol.

Instant Access to Structured Evidence-Based Regimens

References

Surgical resection or curettage treatments have success rates of 88 to 97%.

Percutaneous thermal ablation treatments, including radiofrequency, cryoablation, and laser ablation, have replaced open surgery as the first-line minimally invasive treatment at many institutions worldwide.

DOI: 10.1055/s-0043-1767692

View source ↗